| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/04/1994 | WO1993025583A3 Proteinoid carriers and methods for preparation and use thereof |
| 08/04/1994 | DE4329952C1 New monoclonal antibodies with high specificity for pyrethroid(s) |
| 08/04/1994 | CA2154896A1 Immunoreactive reagents employing heterodimers |
| 08/04/1994 | CA2154882A1 Tata-binding protein associated factors, nucleic acids encoding tafs, and methods of use |
| 08/04/1994 | CA2154487A1 Vaccines and methods for preventing and treating fescue toxicosis in herbivores |
| 08/04/1994 | CA2154346A1 Prevention and treatment of cytomegalovirus using aminopeptidase |
| 08/04/1994 | CA2154278A1 Anti-lfa-1 monoclonal antibodies used for the preparation of a medecine prenventing the rejection of grafted organs |
| 08/04/1994 | CA2153802A1 Chimeric selectins as simultaneous blocking agents for component selectin function |
| 08/04/1994 | CA2153790A1 Human monoclonal antibodies to cytomegalovirus |
| 08/04/1994 | CA2152676A1 Assay method to rule out rupture of membranes in women at risk for imminent delivery |
| 08/04/1994 | CA2132637A1 Icam-related protein |
| 08/04/1994 | CA2132632A1 Anti-zona pellucida antibodies for delivery of therapeutic agents to the ovary |
| 08/03/1994 | EP0608546A2 Glia activating factor (GAF), antibodies against it and their uses |
| 08/03/1994 | EP0608334A1 Sperm surface protein |
| 08/03/1994 | EP0608261A1 Immunoreactive hepatitis c virus polypeptide compositions |
| 08/03/1994 | EP0608212A1 Method of treating viral infection |
| 08/03/1994 | EP0339097B1 Method for diagnosis of liver cancer |
| 08/02/1994 | US5334708 Method for radiolabeling monovalent antibody fragments |
| 08/02/1994 | US5334702 Compositions which are immunologically crossreactive with antibodies and preparative methods therefor |
| 08/02/1994 | US5334617 Preventing food spoilage and animal protein aging |
| 08/02/1994 | US5334528 Monoclonal antibodies to cyclodiene insecticides and method for detecting the same |
| 08/02/1994 | US5334391 Intracellularly cleavable compounds |
| 08/02/1994 | CA2113669A1 Monoclonal antibody that distinguishes between phosphorylated and nonphosphorylated histone h1, and uses therefor |
| 08/02/1994 | CA1331158C Method, device and kit for measurement of tissue plasminogen activator activity |
| 08/02/1994 | CA1331134C Purification of pertussis toxins |
| 08/02/1994 | CA1331132C Method of treatment for non-specific inflammation |
| 07/27/1994 | EP0608117A2 Antibodies for mevalonic acid and methods for determination of mevalonic acid |
| 07/27/1994 | EP0608004A2 Human DNA in the diagnosis of retinoblastoma |
| 07/27/1994 | EP0607425A1 Epstein-barr virus peptides and antibodies against these peptides |
| 07/27/1994 | EP0607408A1 Transvascular and intracellular delivery of lipidized proteins |
| 07/27/1994 | EP0607353A1 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 07/27/1994 | EP0607332A1 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 07/27/1994 | EP0607327A1 Covalently reactive particles incorporated in a continuous porous matrix |
| 07/27/1994 | EP0607297A1 Hormone analogs with multiple ctp extensions |
| 07/27/1994 | EP0607247A1 Production of gpa neurotrophic factor |
| 07/27/1994 | EP0607222A1 Dendrimeric polychelants |
| 07/27/1994 | EP0607206A1 Composition for inserting nucleic acid complexes into higher eucaryotic cells |
| 07/27/1994 | EP0576589A4 Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers |
| 07/27/1994 | EP0491713B1 Rubella e1 and c peptides |
| 07/27/1994 | CA2114160A1 Agents and method for identifying insects |
| 07/26/1994 | US5332678 Cleaving s-s bond with lipoic acid, vitamin B12, testosterone, thyroid hormones |
| 07/26/1994 | US5332670 Which binds only after activation of the resting platelets |
| 07/26/1994 | US5332665 Species specific, high affinity monoclonal antibodies |
| 07/26/1994 | US5332664 Human calcitonin precursor polyprotein structural gene |
| 07/26/1994 | CA1330961C Auto-anti-idiotypic monoclonal antibodies to steroid receptors and uses thereof |
| 07/21/1994 | WO1994016094A2 Recombinant anti-vla4 antibody molecules |
| 07/21/1994 | WO1994016093A1 Antibodies specific for ehv-1 and the use of such antibodies in the detection of ehv-1 |
| 07/21/1994 | WO1994016066A1 Agents for the prevention and treatment of hiv replication and aids in humans |
| 07/21/1994 | WO1994015969A1 Recombinant anti-hiv antibody and preparation thereof |
| 07/21/1994 | WO1994015966A1 Growth differentiation factor-9 |
| 07/21/1994 | WO1994015965A1 Growth differentiation factor-3 |
| 07/21/1994 | WO1994015950A1 Purification of immunoglobulin |
| 07/21/1994 | WO1994015949A1 Growth differentiation factor-5 |
| 07/21/1994 | WO1994015644A1 Compounds for targeting |
| 07/21/1994 | WO1994015642A1 Methods of delivering agents to target cells |
| 07/21/1994 | WO1994015641A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof |
| 07/21/1994 | WO1994015640A1 Methods and compositions for the direct concentrated delivery of passive immunity |
| 07/21/1994 | WO1994015639A1 Methods for inducing long-term immunological non-responsiveness to allografts |
| 07/21/1994 | WO1994015638A1 Antibodies directed against binding-associated epitopes |
| 07/21/1994 | WO1994015637A2 Prevention of suppression of immune defense against cancer caused by the cancer-associated scm-recognition peptides |
| 07/21/1994 | WO1994015633A1 ANTI-CANCER UTILITY OF hCG VACCINES |
| 07/21/1994 | WO1994015618A1 Dna encoding a human betaine/gaba transporter and uses thereof |
| 07/21/1994 | WO1994015593A1 Novel parasitic helminth proteins |
| 07/21/1994 | WO1994012625A3 LIGAND BINDING VARIABLE DOMAIN (V-MIN) COMPRISING A FRAMEWORK REGION WITH A CYCLICALLY PERMUTED CENTRAL β-BARREL |
| 07/21/1994 | WO1994012144A3 Treatment of infertility and enhancement of fertilization capacity in mammalian males |
| 07/21/1994 | CA2153776A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof |
| 07/21/1994 | CA2153661A1 Methods and compositions for the direct concentrated delivery of passive immunity |
| 07/21/1994 | CA2153654A1 Growth differentiation factor-5 |
| 07/21/1994 | CA2153652A1 Growth differentiation factor-3 |
| 07/21/1994 | CA2153568A1 Methods of delivering agents to target cells |
| 07/21/1994 | CA2153046A1 Dna encoding a human betaine/gaba transporter and uses thereof |
| 07/21/1994 | CA2152915A1 Antibodies directed against binding-associated epitopes |
| 07/21/1994 | CA2131623A1 Prevention of suppression of immune defence against cancer caused by the cancer-associated scm-recognition peptides |
| 07/21/1994 | CA2131165A1 Anti-cancer utility of hcg vaccines |
| 07/21/1994 | CA2113866A1 Antibodies for mevalonic acid and methods for determination of mevalonic acid |
| 07/20/1994 | EP0607054A2 Novel process for constructing a cDNA library and a novel polypeptide and DNA coding the same |
| 07/20/1994 | EP0606921A1 Method of isolating haemophilus influenzae protein E |
| 07/20/1994 | EP0606734A1 Human CNS receptors of the NMDA-R1 family |
| 07/20/1994 | EP0606518A1 Intercellular adhesion molecules and their binding ligands |
| 07/20/1994 | EP0606516A1 Anti-human ceruloplasmin monoclonal antibody |
| 07/20/1994 | EP0606430A1 Chimeric anti-cea antibody |
| 07/20/1994 | EP0606411A1 Novel compounds and conjugates |
| 07/20/1994 | EP0606391A1 Inhibition of vascular narrowing using anti-padgem antibodies |
| 07/20/1994 | EP0606280A1 New conjugates for the introduction of nucleic acid into higher eukaryotic cells |
| 07/20/1994 | EP0606217A1 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 07/20/1994 | EP0522086B1 DNA SEQUENCE ENCODING GALACTOPROTEIN b3 |
| 07/20/1994 | EP0484406B1 Polypeptide inhibitor of viral replication |
| 07/20/1994 | EP0470989B1 Use of anti-B2 microglobulin monoclonal antibodies |
| 07/20/1994 | CN1089660A Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for......... |
| 07/19/1994 | US5331573 Method of design of compounds that mimic conformational features of selected peptides |
| 07/19/1994 | US5331109 Phencyclidine derivatives and protein and polypeptide phencyclidine derivative conjugates and labels |
| 07/19/1994 | US5331094 Purified active somatostatin receptor |
| 07/19/1994 | US5331093 Anti-focosylceramide monoclonal antibody |
| 07/19/1994 | US5331090 CR2 ligand compositions and methods for modulating immune cell functions |
| 07/19/1994 | US5330910 Immunoassay |
| 07/19/1994 | US5330909 Monoclonal antibody specifically recognizing N-terminal portion of human calcitonin |
| 07/19/1994 | US5330897 Sialic acid binding lectin of protozoan origin |
| 07/19/1994 | US5330896 Monoclonal antibodies to an autocrine growth factor antigen that binds to activated lymphocytes and cancer cells |
| 07/19/1994 | US5330895 Detection reagent and antibody specific for dopamine releasing protein |
| 07/19/1994 | US5330894 Anti-procollagenase monoclonal antibodies and a method for the assay of procollagenase utilizing thereof |